UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14-A
(Rule 14A-101)
PROXY STATEMENT PURSUANT TO SECTION 14(a)
OF THE SECURITIES AND EXCHANGE ACT OF 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
o Preliminary Proxy Statement
o Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
o Definitive Additional Materials
þ Soliciting Materials Pursuant to Section 240.14a.12
LCA-Vision Inc.
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ No fee required.
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11
1) | Title of each class of securities to which the transaction applies: __________________________________________________________________ |
2) | Aggregate number of securities to which transaction applies: __________________________________________________________________ |
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): __________________________________________________________________ |
4) | Proposed maximum aggregate value of transaction: __________________________________________________________________ |
5) | Total fee paid: |
o Fee paid previously with preliminary materials
o | Check box if any part of the fee is offset by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
1. | Amount Previously Paid: __________________________________________________________________ |
2. | Form, Schedule or Registration No.: __________________________________________________________________ |
3. | Filing Party: __________________________________________________________________ |
4. | Date Filed: __________________________________________________________________ |
On December 29, 2008, LCA-Vision Inc. issued the following press release:
LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group’s Threatened Consent Solicitation
CINCINNATI (December 29, 2008) – The LCA-Vision Inc. (NASDAQ: LCAV) Board of Directors strongly opposes the consent solicitation threatened by the Joffe group. The Board believes that the Company has undertaken a prudent and achievable strategic plan to return the Company to profitability and that the Joffe intervention is a poorly designed effort to take control of your Company. The Board further believes that the Joffe effort is an undue distraction to the Company that would damage shareholder value. The Board of Directors strongly encourages stockholders to refrain from taking any action regarding the Joffe group’s consent solicitation until they have had the benefit of the Board’s recommendation and accompanying explanation.
About LCA-Vision Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus® brand, operates 77 LasikPlus® fixed-site laser vision correction centers in 33 states and 59 markets in the United States and a joint venture in Canada. Additional company information is available at http://www.lca-vision.com/ and http://www.lasikplus.com/.
Disclaimer
In connection with a possible consent solicitation by certain stockholders to remove and replace the Board of Directors of the Company, the Company plans to file a consent revocation statement solicitation with the Securities and Exchange Commission. THE COMPANY URGES INVESTORS TO READ THE CONSENT REVOCATION STATEMENT (INCLUDING ANY SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders will be able to obtain, free of charge, copies of the consent revocation statement and any other documents filed by the Company with the SEC in connection with the consent solicitation at the SEC’s website at http://www.sec.gov and at the Company’s website at http://www.lasikplus.com.
LCA-Vision Inc. and its directors and certain executive officers may be deemed to be participants in the solicitation of consent revocations from stockholders. Information regarding the names of the Company’s directors and executive officers and their respective interests in the Company by security holdings or otherwise is set forth in the Company’s proxy statement relating to the 2008 annual meeting of stockholders, which may be obtained free of charge at the SEC’s website at http://www.sec.gov and the Company’s website at http://www.lasikplus.com or by contacting Georgeson, 199 Water Street, 26th Floor, New York, NY 10038 by calling (212) 440-9800 (bankers and brokers) or toll-free (800) 457-0109 (all others). Additional information regarding the interests of such potential participants will be included in the consent revocation statement and other relevant documents to be filed with the SEC in connection with the Consent Solicitation.
Earning Trust Every Moment.
Transforming Lives Every Day.
For Additional Information
Company Contact: | Investor Relations Contact: | |
Barb Kise | Jody Cain | |
LCA-Vision Inc. | Lippert/Heilshorn & Associates | |
513-792-9292 | 310-691-7100 |